Immunofluorescence staining of the xenograft tumor tissue samples demonstrated that alisertib treatment not only decreased xenograft tumor size but also significantly reduced phospho-IRE1α (p-IRE1α) staining, as compared with control tumor samples (Figure 7A,B and Supplementary Figure S6, p < 0.01). This evidence concerns the gene ERN1 and neoplasm.